Form 4 for AEHR AEHR TEST SYSTEMS
Accepted 2022-04-20 00:00:00 ET · period of report 2022-04-20 · accession 0001654954-22-005225 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-20 | 2022-04-20 | AEHR | Erickson Gayn | Pres, CEO, Dir | M - OptEx | $2.10 | +27.1K | 507.5K | +6% | +$57.0K |
| D | 2022-04-20 | 2022-04-20 | AEHR | Erickson Gayn | Pres, CEO, Dir | M - OptEx | $0.00 | -27.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-20 | M | A | 27,120 | $2.10 | 507,543 | D | — | — | (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 2 | Derivative | Incentive Stock Option (right to buy) | 2022-04-20 | M | D | 27,120 | $0.00 | 0 | D | $2.10 · 2015-05-21 to 2022-04-21 | 27,120 Common Stock | (F2) One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. |